AMES, Iowa, Feb. 19, 2015 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (Nasdaq:NLNK) will release its fourth quarter and year end 2014 financial results on Thursday, February 26, 2015. The company has scheduled a conference call for 8:30 AM ET the same day to discuss the results and review accomplishments and progress in its clinical and business development activities.
NewLink's senior management team will host the conference call, which will be open to all listeners. There will also be a question and answer session following the prepared remarks.
Access to the live call is available by dialing (855) 469-0612 (domestic) or (484) 756-4268 (international) five minutes prior to the start of the call. The call can also be accessed through a webcast via a link provided on the Investors and Media homepage of NewLink's website at www.linkp.com. A replay of the call will be available approximately two hours after the completion of the call and can be accessed by dialing (855) 859-2056 (domestic) or (404) 537-3406 (international) and using the passcode 88421787. The replay will be available for two weeks from the date of the call and the webcast will also be archived on the website.
NewLink is a biopharmaceutical company focused on discovering, developing and commercializing novel immuno-oncology products to improve treatment options for patients with cancer. NewLink's portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a wide range of oncology indications. NewLink's product candidates are designed to harness multiple components of the immune system to combat cancer without significant incremental toxicity, either as a monotherapy or in combination with other treatment regimens. For more information please visit http://www.linkp.com.
CONTACT: Investor Contact: Jack Henneman Chief Financial Officer 515-598-2561 Investor@Linkp.com
Source:NewLink Genetics Corporation